| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Eleftherios Mantonakis | Q82450114 |
| Efthymios Avgerinos | Q38641276 | ||
| P2093 | author name string | Demetrios Moris | |
| Emmanuel Pikoulis | |||
| Sotirios Georgopoulos | |||
| Chris Bakoyiannis | |||
| Marinos Makris | |||
| P2860 | cites work | Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1 | Q24629883 |
| Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms | Q28202574 | ||
| Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin | Q28249401 | ||
| TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis | Q28257134 | ||
| Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint | Q28481255 | ||
| Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl-D-aspartate receptor. | Q31905687 | ||
| Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis | Q33271663 | ||
| Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm | Q33575645 | ||
| Discovery of a novel circulating biomarker in patients with abdominal aortic aneurysm: a pilot study using a proteomic approach | Q33713557 | ||
| Analysis of positional candidate genes in the AAA1 susceptibility locus for abdominal aortic aneurysms on chromosome 19. | Q33797335 | ||
| Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm | Q33805812 | ||
| Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. | Q33886784 | ||
| A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. | Q34129962 | ||
| Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion | Q34325894 | ||
| Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms | Q34425003 | ||
| Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial | Q34428981 | ||
| Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial | Q34428985 | ||
| Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm | Q35126452 | ||
| Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II | Q35831907 | ||
| Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies | Q35948644 | ||
| Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study | Q36109507 | ||
| Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein | Q69593309 | ||
| Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms | Q80848315 | ||
| Elective versus ruptured abdominal aortic aneurysm repair: a 1-year cost-effectiveness analysis | Q81247314 | ||
| Emerging paradigms, platforms, and unifying themes in biomarker science | Q81506783 | ||
| The role of the CCR2 gene polymorphism in abdominal aortic aneurysms | Q83160962 | ||
| Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease | Q84770553 | ||
| Tenascin-C is expressed in abdominal aortic aneurysm tissue with an active degradation process | Q84997793 | ||
| Endovascular vs open repair of acute abdominal aortic aneurysms--a systematic review and meta-analysis | Q37074876 | ||
| Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture--a systematic review. | Q37221187 | ||
| Circulating lipoprotein(a) concentrations and abdominal aortic aneurysm presence | Q37535304 | ||
| The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines | Q37604613 | ||
| Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass | Q37723728 | ||
| Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis | Q37776648 | ||
| Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. | Q37826901 | ||
| An economic evaluation of an abdominal aortic aneurysm screening program in Italy | Q37912616 | ||
| Population screening for abdominal aortic aneurysm: evaluating the evidence against screening criteria | Q37989778 | ||
| Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm | Q38510939 | ||
| The role of tenascin-C in tissue injury and tumorigenesis | Q39280466 | ||
| Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms. | Q39716278 | ||
| Influence of presentation on outcome in abdominal aortic aneurysm repair. | Q42018360 | ||
| Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms | Q42071134 | ||
| CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers | Q42108377 | ||
| A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation | Q42109762 | ||
| A pilot study on low-density lipoprotein receptor-related protein-1 in Chinese patients with abdominal aortic aneurysm | Q42619278 | ||
| Endovascular versus open repair of abdominal aortic aneurysm | Q42656213 | ||
| Association between serum lipoproteins and abdominal aortic aneurysm | Q43069503 | ||
| Association of polymorphisms on chromosome 9p21.3 region with increased susceptibility of abdominal aortic aneurysm in a Chinese Han population. | Q43736495 | ||
| Short leukocyte telomere length is associated with abdominal aortic aneurysm (AAA). | Q44528927 | ||
| Yield of repeated screening for abdominal aortic aneurysm after a 4-year interval. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators | Q45334604 | ||
| Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease | Q45766822 | ||
| Lymphangiogenesis in abdominal aortic aneurysm. | Q45942172 | ||
| Macrophage migration inhibitory factor is associated with aneurysmal expansion | Q46086580 | ||
| Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma | Q46177523 | ||
| Association of osteoprotegerin with human abdominal aortic aneurysm progression | Q46531394 | ||
| Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose-response relationship? | Q46958991 | ||
| The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms | Q47708115 | ||
| Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels | Q47819405 | ||
| Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease | Q47882485 | ||
| From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm. | Q50477791 | ||
| A comparative study of the prevalence of abdominal aortic aneurysms in the United Kingdom, Denmark, and Australia. | Q50568745 | ||
| Long-term survival and temporal trends in patient and surgeon factors after elective and ruptured abdominal aortic aneurysm surgery. | Q50745171 | ||
| Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. | Q50745596 | ||
| C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. | Q50747410 | ||
| Plasma total homocysteine is associated with abdominal aortic aneurysm and aortic diameter in older men. | Q51020216 | ||
| Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome. | Q51576481 | ||
| Ultrasound measurement of aortic diameter in a national screening programme. | Q53082557 | ||
| Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm. | Q53175597 | ||
| Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. | Q53296696 | ||
| Endovascular repair of ruptured abdominal aortic aneurysm--a challenge to open repair? Results of a single centre experience in 20 patients. | Q53882053 | ||
| Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. | Q54517675 | ||
| Telomerase expression on aortic wall endothelial cells is attenuated in abdominal aortic aneurysms compared to healthy nonaneurysmal aortas. | Q54560596 | ||
| The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm | Q56891289 | ||
| Association Study of Single Nucleotide Polymorphisms on Chromosome 19q13 With Abdominal Aortic Aneurysm | Q56893394 | ||
| The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm | Q56901479 | ||
| Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm | Q57245499 | ||
| Proteomic Analysis of Polymorphonuclear Neutrophils Identifies Catalase as a Novel Biomarker of Abdominal Aortic Aneurysm: Potential Implication of Oxidative Stress in Abdominal Aortic Aneurysm Progression | Q57245501 | ||
| Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms | Q57446117 | ||
| Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms | Q57607651 | ||
| Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio | Q57767325 | ||
| Serum secreted phospholipase A2 is associated with abdominal aortic aneurysm presence but not progression | Q58148724 | ||
| A proteomic approach to identify plasma proteins in patients with abdominal aortic aneurysm | Q58464307 | ||
| Increased Circulating Levels of Basement-Membrane Components in Patients With Abdominal Aortic Aneurysms – A Pilot Study | Q59549932 | ||
| Low-density lipoprotein receptor-related protein 5 gene polymorphisms and genetic susceptibility to abdominal aortic aneurysm | Q62607028 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| abdominal aortic aneurysm | Q2256736 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 925840 | |
| P577 | publication date | 2014-01-01 | |
| 2014-05-20 | |||
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptions | |
| P478 | volume | 2014 |
| Q38261342 | 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms: a useful biomarker of AAA rupture risk |
| Q36284164 | A mathematical model of aortic aneurysm formation |
| Q28081610 | An Update on the Inflammatory Response after Endovascular Repair for Abdominal Aortic Aneurysm |
| Q52643109 | Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis. |
| Q39392202 | Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size |
| Q57293166 | Pentagalloyl Glucose and Its Functional Role in Vascular Health: Biomechanics and Drug-Delivery Characteristics |
| Q89556458 | Tissue-specific relaxin-2 is differentially associated with the presence/size of an arterial aneurysm and the severity of atherosclerotic disease in humans |
Search more.